Retatrutide for the treatment of obesity, obstructive sleep apnea and the TRIUMPH clinical development programme
For Wegovy to be HSA/FSA-eligible, you need an LMN indicating that weight reduction is of specific and timely relevance to your physical health, and not a general or aesthetic pursuit
The testing culture sounds reassuring until you look at what the labs find
I truly wanted to help people on their weight loss journey, but the answers always seem to come back to very restrictive interventions people struggled to follow
GLP-1 drugs are at the center of this transition, acting as a bridge between traditional metabolic care and newer, more patient-driven models
Hims CEO Andrew Dudum takes a GLP-1 microdose, he told Bloomberg earlier this year